NCT06983704View on ClinicalTrials.gov

Assessing Combined Bevacizumab-Mitomycin C Use During Ahmed Valve Revision in Recurrent Pediatric Glaucoma

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 9, 2024

Primary Completion Date

February 8, 2025

Study Completion Date

February 15, 2025

Conditions
Pediatric Glaucoma
Interventions
PROCEDURE

AGV plate

AGV plate using a 27-gauge needle

PROCEDURE

bevacizumab injection

subconjunctival injection of bevacizumab

Trial Locations (1)

Unknown

Al-Azhar University, Cairo

All Listed Sponsors
lead

Benha University

OTHER

NCT06983704 - Assessing Combined Bevacizumab-Mitomycin C Use During Ahmed Valve Revision in Recurrent Pediatric Glaucoma | Biotech Hunter | Biotech Hunter